Evidence map›Paper›PMID 42106330›Full record

ArticleNature communications2026

Short-term action is key for gigaton-scale Direct Air Capture by 2050.

Tatjana Zurbriggen, Nicoletta Brazzola, Adrian Odenweller, Falko Ueckerdt, Joeri Rogelj

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatjana ZurbriggenInstitute for Environmental Decisions (IED), ETH Zürich, Zurich, Switzerland.
Nicoletta BrazzolaInstitute for Environmental Decisions (IED), ETH Zürich, Zurich, Switzerland. nicoletta.brazzola@swp-berlin.org.
Adrian OdenwellerPotsdam Institute for Climate Impact (PIK), Potsdam, Germany.ORCID http://orcid.org/0000-0002-1123-8124
Falko UeckerdtPotsdam Institute for Climate Impact (PIK), Potsdam, Germany.
Joeri RogeljCentre for Environmental Policy (CEP) and Grantham Institute - Climate Change and Environment, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-2056-9061

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 03SFK5ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 03SFK5A0-2Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 333151Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) P000PS_203884
6 · The paper itself

Abstract

Direct Air Capture (DAC) is widely considered essential for achieving net-zero and net-negative emissions, yet its potential to scale to climate-relevant levels remains uncertain. Here we show that the future deployment of DAC depends primarily on early capacity expansion and growth dynamics rather than on long-term demand targets alone. Using a probabilistic technology diffusion model informed by historical analog technologies and uncertain future demand, we explore a wide range of possible global DAC deployment pathways to 2050. We find that if DAC follows growth trajectories similar to ammonia synthesis technologies and liquefied natural gas, deployment is likely to remain at the megaton scale by mid-century. However, gigaton-scale deployment becomes plausible under rapid growth and strong early policy support. Our results identify short-term capacity expansion as the most effective lever for accelerating DAC deployment and highlight the critical importance of timely policy action to avoid overreliance on future large-scale carbon removal.

Identifiers

PMID42106330
PMCPMC13370031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.